Zhen Wang

Relative Abundance of <i>EGFR</i> Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

Qing Zhou, Xu‐Chao Zhang, Zhihong Chen et al. · Journal of Clinical Oncology · 2011 · 241 citations

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study

Qing Zhou, Chong‐Rui Xu, Ying Cheng et al. · Cancer Cell · 2021 · 220 citations

Advanced Nsclc, Novel Therapy, Multicenter Phase 3 +9

Lung Cancers with Concomitant <i>EGFR</i> Mutations and <i>ALK</i> Rearrangements: Diverse Responses to EGFR-TKI and Crizotinib in Relation to Diverse Receptors Phosphorylation

Jin-Ji Yang, Xu‐Chao Zhang, Jian Su et al. · Clinical Cancer Research · 2014 · 165 citations

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

Hanmin Wang, Chan-Yuan Zhang, Kai‐Cheng Peng et al. · Cell Reports Medicine · 2023 · 163 citations · Full text

Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer

Song Dong, Zhen Wang, Jia‐Tao Zhang et al. · JAMA Oncology · 2024 · 54 citations · Full text